Does INOTUZUMAB OZOGAMICIN Cause Off label use? 146 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 146 reports of Off label use have been filed in association with INOTUZUMAB OZOGAMICIN (Besponsa). This represents 6.3% of all adverse event reports for INOTUZUMAB OZOGAMICIN.
146
Reports of Off label use with INOTUZUMAB OZOGAMICIN
6.3%
of all INOTUZUMAB OZOGAMICIN reports
63
Deaths
38
Hospitalizations
How Dangerous Is Off label use From INOTUZUMAB OZOGAMICIN?
Of the 146 reports, 63 (43.2%) resulted in death, 38 (26.0%) required hospitalization, and 13 (8.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INOTUZUMAB OZOGAMICIN. However, 146 reports have been filed with the FAERS database.
What Other Side Effects Does INOTUZUMAB OZOGAMICIN Cause?
Death (253)
Febrile neutropenia (230)
Venoocclusive liver disease (229)
Neoplasm progression (158)
Pyrexia (151)
Sepsis (119)
Venoocclusive disease (109)
Thrombocytopenia (108)
Platelet count decreased (107)
Drug ineffective (92)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which INOTUZUMAB OZOGAMICIN Alternatives Have Lower Off label use Risk?
INOTUZUMAB OZOGAMICIN vs INSULIN
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART\INSULIN DEGLUDEC
INOTUZUMAB OZOGAMICIN vs INSULIN BEEF
INOTUZUMAB OZOGAMICIN vs INSULIN DEGLUDEC